This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Clinical Feasibility Study of Allium's Biliary Stent

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2007 by Allium, Ltd..
Recruitment status was:  Not yet recruiting
Information provided by:
Allium, Ltd. Identifier:
First received: March 14, 2007
Last updated: NA
Last verified: March 2007
History: No changes posted
The purpose of this study is to evaluate the safety and efficacy of the Allium Biliary Stent in malignant obstructions of the common bile duct.

Condition Intervention
Malignant Obstruction of the Common Bile Duct Device: Allium Biliary Stent

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Clinical Feasibility Study to Evaluate the New Allium Biliary Stent, in Patients Suffering From “Malignant Biliary Duct Obstruction” (Endoscopic Insertion)

Further study details as provided by Allium, Ltd.:

Primary Outcome Measures:
  • Body temperature measurement, patient comfort analysis, sonographic measurements of the duct channels, abdominal X-ray imaging of the stent, and blood tests will be performed at 24 hours, 30 days, 3, 6, and 12 months following stent insertion.

Estimated Enrollment: 30
Study Start Date: April 2007
Estimated Study Completion Date: December 2008
Detailed Description:
Biliary duct stenoses are caused by intrinsic malignant disease of the common bile duct or by compression or infiltration of malignancies of the abdominal organs, i.e. pancreas, liver, stomach, duodenum, etc, or by iatrogenic reasons such as endoscopic biliary stone manipulations, biliary anastomoses or biliary duct reimplantation. In these diseases, a stent can be placed in the biliary duct canal to “open it” and relieve the obstruction. The Allium Biliary Stent is to be inserted into the biliary duct to allow free flow of biliary fluid from the liver to the duodenum by supporting the obstructed area of the biliary duct lumen, keep it open, and prevent its re-obstruction.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patient is 18 years or older
  • Patient has malignant obstructive jaundice
  • Patient is unfit for surgery
  • Patient is capable of giving informed consent
  • Patient is willing to comply with study requirements

Exclusion Criteria:

  • Patient has a benign biliary duct obstruction
  • Patient cannot tolerate any form of antibiotic treatment
  • Patient is currently receiving anticoagulation therapy
  • Patient has history of illness, medication, or surgery that may affect the efficacy of the stent (e.g.: a previous surgical change in the anatomy of the common bile duct)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00448006

Contact: Simon Bar-Meir, M.D. +972-3-530-2909

Sheba Medical Center Not yet recruiting
Ramat Gan, Israel
Sub-Investigator: Simon Bar-Meir, M.D.         
Principal Investigator: Carlos Simon, M.D.         
Sub-Investigator: Alon Lang, M.D.         
Sub-Investigator: Maor Lahav, M.D.         
Sponsors and Collaborators
Allium, Ltd.
Principal Investigator: Simon Bar-Meir, M.D. Sheba Medical Center
  More Information

Additional Information: Identifier: NCT00448006     History of Changes
Other Study ID Numbers: BIS-CL-001
Study First Received: March 14, 2007
Last Updated: March 14, 2007

Keywords provided by Allium, Ltd.:
stent processed this record on September 21, 2017